Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 745, pseudogene (RNU6-745P) is a *processed pseudogene* of the U6 small nuclear RNA (snRNA) family. U6 snRNA is a core component of the spliceosome, the cellular machinery responsible for pre-messenger RNA (pre-mRNA) splicing in eukaryotes. U6 snRNA itself is highly conserved and essential for splicing, forming a critical part of the spliceosomal active site[1][3]. However, RNU6-745P is a copy of the U6 snRNA gene which has acquired sequence changes or truncations such that it does not encode a functional RNA, nor is it known to be transcribed into a functional molecule. Like many other snRNA pseudogenes, it is found in the human genome as part of the evolutionary proliferation of small RNA gene copies[3]. While some pseudogenes have been found to exert regulatory effects—for example, by acting as competitive endogenous RNAs or through antisense mechanisms—such roles have not been established for RNU6-745P or for most U6 pseudogenes[2]. As such, this pseudogene is not considered a receptor, enzyme, transporter, or otherwise a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 745, pseudogene (RNU6-745P).